期刊文献+

Using a novel cellular platform to optimize CRISPR/CAS9 technology for the gene therapy of AIDS 被引量:2

Using a novel cellular platform to optimize CRISPR/CAS9 technology for the gene therapy of AIDS
原文传递
导出
摘要 Dear Editor,Despite tremendous effort devoted to the development of antiretroviral therapies to combat HIV over the past decades, AIDS remains one of the most important global infectious diseases. According to UNAIDS report on the global AIDS epidemic in 2016, the estimated number of people living with HIV rose from 7.5 million in 2010 to 36.7 million in 2015. Furthermore, drug-resistance HIV strains have recently been reported (Wensing et al., 2017). Therefore, it is important to develop new therapies to eliminate HIV in the patients. Immortalized cell lines representing the major targets of HIV in human are important for HIV research and therapeutic development. Dear Editor,Despite tremendous effort devoted to the development of antiretroviral therapies to combat HIV over the past decades, AIDS remains one of the most important global infectious diseases. According to UNAIDS report on the global AIDS epidemic in 2016, the estimated number of people living with HIV rose from 7.5 million in 2010 to 36.7 million in 2015. Furthermore, drug-resistance HIV strains have recently been reported (Wensing et al., 2017). Therefore, it is important to develop new therapies to eliminate HIV in the patients. Immortalized cell lines representing the major targets of HIV in human are important for HIV research and therapeutic development.
出处 《Protein & Cell》 SCIE CAS CSCD 2017年第11期848-852,共5页 蛋白质与细胞(英文版)
关键词 novel cellular platform optimize CRISPR/CAS9 technology the gene therapy of AIDS novel cellular platform optimize CRISPR/CAS9 technology the gene therapy of AIDS
  • 相关文献

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部